TY - JOUR
T1 - Dr. Gary J. Becker Young Investigator Award
T2 - Comparison of small-diameter type 1 collagen stent-grafts and PTFE stent-grafts in a canine model - Work in progress
AU - Kallmes, David F.
AU - Lin, Horng Ban
AU - Fujiwara, Naomi H.
AU - Short, John G.
AU - Hagspiel, Klaus D.
AU - Li, Shu Tung
AU - Matsumoto, Alan H.
PY - 2001
Y1 - 2001
N2 - PURPOSE: To report an in-progress experiment in a canine model in which two types of small-diameter stent-grafts - one constructed of polytetrafluoroethylene (PTFE) and the other of a new, type 1 collagen material - were compared regarding vessel patency, intimal hyperplasia formation, and tissue reaction. MATERIALS AND METHODS: Six mongrel dogs weighing 30-35 kg were used. Stent-grafts of 4-mm diameter and 20-mm length were constructed with use of balloon-expandable stainless-steel stents wrapped with either PTFE or a new type 1 collagen graft. Stent-grafts were placed in deep femoral arteries bilaterally (PTFE on one side, collagen on the other). Animals were followed for 2 weeks (n = 2), 6 weeks (n = 2), or 12 weeks (n = 2). Percent stenosis based on angiographic findings as well as thickness and area of neointimal hyperplasia were compared at each time point and compared with use of the Student t test. RESULTS: All devices were patent in the immediate postimplantation period. Five of six collagen stent-grafts and five of six PTFE implants were patent at follow-up. In-stent stenosis was undetectable angiographically in all five patent collagen stent-grafts. All five patent PTFE stent-grafts showed demonstrable in-stent stenosis (10%-60%), indicating a trend toward improved patency in collagen stent-grafts versus PTFE stent-grafts (P = .07). Neointimal hyperplasia was absent at 2 weeks in the collagen stent-grafts. Neointimal thickness increased to a maximum of 360 μm at 12 weeks in the collagen stent-grafts. For PTFE stent-grafts, neointimal hyperplasia was present in all samples and reached a maximum of 770 μm at 12 weeks (P = .03). CONCLUSIONS: Even in small-diameter vessels, type 1 collagen stent-grafts demonstrate excellent patency rates and favorable histologic findings. The type 1 collagen stent-graft technology merits further developmental efforts in preclinical models.
AB - PURPOSE: To report an in-progress experiment in a canine model in which two types of small-diameter stent-grafts - one constructed of polytetrafluoroethylene (PTFE) and the other of a new, type 1 collagen material - were compared regarding vessel patency, intimal hyperplasia formation, and tissue reaction. MATERIALS AND METHODS: Six mongrel dogs weighing 30-35 kg were used. Stent-grafts of 4-mm diameter and 20-mm length were constructed with use of balloon-expandable stainless-steel stents wrapped with either PTFE or a new type 1 collagen graft. Stent-grafts were placed in deep femoral arteries bilaterally (PTFE on one side, collagen on the other). Animals were followed for 2 weeks (n = 2), 6 weeks (n = 2), or 12 weeks (n = 2). Percent stenosis based on angiographic findings as well as thickness and area of neointimal hyperplasia were compared at each time point and compared with use of the Student t test. RESULTS: All devices were patent in the immediate postimplantation period. Five of six collagen stent-grafts and five of six PTFE implants were patent at follow-up. In-stent stenosis was undetectable angiographically in all five patent collagen stent-grafts. All five patent PTFE stent-grafts showed demonstrable in-stent stenosis (10%-60%), indicating a trend toward improved patency in collagen stent-grafts versus PTFE stent-grafts (P = .07). Neointimal hyperplasia was absent at 2 weeks in the collagen stent-grafts. Neointimal thickness increased to a maximum of 360 μm at 12 weeks in the collagen stent-grafts. For PTFE stent-grafts, neointimal hyperplasia was present in all samples and reached a maximum of 770 μm at 12 weeks (P = .03). CONCLUSIONS: Even in small-diameter vessels, type 1 collagen stent-grafts demonstrate excellent patency rates and favorable histologic findings. The type 1 collagen stent-graft technology merits further developmental efforts in preclinical models.
KW - Endovascular stent-grafts
KW - SCVIR Annual Meeting, 2001
KW - Stents and prostheses
UR - http://www.scopus.com/inward/record.url?scp=0034770498&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034770498&partnerID=8YFLogxK
U2 - 10.1016/S1051-0443(07)61669-8
DO - 10.1016/S1051-0443(07)61669-8
M3 - Article
C2 - 11585878
AN - SCOPUS:0034770498
SN - 1051-0443
VL - 12
SP - 1127
EP - 1133
JO - Journal of Vascular and Interventional Radiology
JF - Journal of Vascular and Interventional Radiology
IS - 10
ER -